Quality Control Practices for Chemistry and Immunochemistry in a Cohort of 21 Large Academic Medical Centers.

Autor:	Rosenbaum MW; Department of Pathology, Massachusetts General Hospital, Boston., Flood JG; Department of Pathology, Massachusetts General Hospital, Boston., Melanson SEF; Department of Pathology, Brigham and Women's Hospital, Boston, MA., Baumann NA; Department of Pathology, Mayo Clinic, Rochester, MN., Marzinke MA; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD., Rai AJ; Department of Pathology, New York-Presbyterian Columbia, New York, NY., Hayden J; Department of Pathology, New York-Presbyterian Cornell, New York, NY., Wu AHB; Department of Pathology, UCSF Medical Center, San Francisco, CA., Ladror M; Department of Pathology, Northwestern Memorial Hospital, Chicago, IL., Lifshitz MS; Department of Pathology, Tisch Hospital, NYU Langone Health, New York, NY., Scott MG; Department of Pathology, Barnes-Jewish Hospital/Washington University, St Louis, MO., Peck-Palmer OM; Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA., Bowen R; Department of Pathology, Stanford Health Care, Stanford Hospital, Stanford, CA., Babic N; Department of Pathology, Mount Sinai Hospital, New York, NY., Sobhani K; Department of Pathology, Cedars-Sinai Medical Center, Los Angeles, CA., Giacherio D; Department of Pathology, University of Michigan Hospitals and Health Centers, Ann Arbor., Bocsi GT; Department of Pathology, University of Colorado School of Medicine, Aurora., Herman DS; Department of Pathology, Hospitals of the University of Pennsylvania-Penn Presbyterian, Philadelphia., Wang P; Department of Pathology, Hospitals of the University of Pennsylvania-Penn Presbyterian, Philadelphia., Toffaletti J; Department of Pathology, Duke University Medical Center, Durham, NC., Handel E; Department of Pathology, Duke University Medical Center, Durham, NC., Kelly KA; Department of Pathology, UCLA Medical Center, Los Angeles, CA., Albeiroti S; Department of Pathology, UCLA Medical Center, Los Angeles, CA., Wang S; Department of Pathology, Cleveland Clinic, Cleveland, OH., Zimmer M; Department of Pathology, Cleveland Clinic, Cleveland, OH., Driver B; Department of Pathology, Houston Methodist Hospital, Houston, TX., Yi X; Department of Pathology, Houston Methodist Hospital, Houston, TX., Wilburn C; Department of Pathology, Houston Methodist Hospital, Houston, TX., Lewandrowski KB; Department of Pathology, Massachusetts General Hospital, Boston.
Jazyk:	angličtina
Zdroj:	American journal of clinical pathology [Am J Clin Pathol] 2018 Jul 03; Vol. 150 (2), pp. 96-104.
DOI:	10.1093/ajcp/aqy033
Abstrakt:	Objectives: In the United States, minimum standards for quality control (QC) are specified in federal law under the Clinical Laboratory Improvement Amendment and its revisions. Beyond meeting this required standard, laboratories have flexibility to determine their overall QC program. Methods: We surveyed chemistry and immunochemistry QC procedures at 21 clinical laboratories within leading academic medical centers to assess if standardized QC practices exist for chemistry and immunochemistry testing. Results: We observed significant variation and unexpected similarities in practice across laboratories, including QC frequency, cutoffs, number of levels analyzed, and other features. Conclusions: This variation in practice indicates an opportunity exists to establish an evidence-based approach to QC that can be generalized across institutions.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu